比索洛尔治疗慢性阻塞性肺疾病支气管哮喘重叠综合症合并快速性心律失常患者的疗效分析  

Bisoprolol in the treatment of chronic obstructive pulmonary disease, bronchial asthma overlap syndrome and tachyarrhythmia

作　　者：张琼[1] 刘茂鸿 青措 吴婷 ZHANG Qiong;LIU Mao-hong;QING Cuo;WU Ting

机构地区：[1]郫县人民医院呼吸内科,四川成都611730

出　　处：《中国药物经济学》2018年第12期102-104,共3页China Journal of Pharmaceutical Economics

摘　　要：目的探讨比索洛尔治疗慢性阻塞性肺疾病支气管哮喘重叠综合症(ACOS)合并快速性心律失常患者的临床效果。方法回顾性分析郫县人民医院呼吸内科2016年12月至2017年12月收治的46例ACOS合并快速性心律失常患者,对其实施常规治疗同时加用比索洛尔治疗,动态监测患者心率、血气分析指标改善情况。结果 46例患者服用比索洛尔后,显效28例,有效14例,无效4例,总有效率91.3%(42/46);治疗后患者的静息心率(RHR)明显降低,与治疗前比较,差异有统计学意义(P<0.05)。结论应用小剂量比索洛尔治疗ACOS合并快速性心律失常临床疗效显著,可显著控制患者心率,改善呼吸困难。Objective The clinical efficacy of bisoprolol in the treatment of ACOS and tachyarrhythmia. Methods A retrospective analysis was made on 46 cases of ACOS patients with tachyarrhythmia admitted to the Department of Respiratory Medicine of Pixian People's Hospital from December 2016 to December 2017.The patients were treated with conventional therapy and bisoprolol.The improvement of heart rate and blood gas analysis index was monitored dynamically. Results After received bisoprolol, significantly improved dyspnea (P<0.05). Dyspnea and pulmonary rale were not aggravated, 28 obvious effect, 14 effect and 4 no effect. The total effective rate was 91.3% (42/46).The resting heart rate (RHR) of patients after treatment was significantly lower than that before treatment(P<0.05). Conclusion The clinical effect of low dose bisoprolol in the treatment of ACOS with tachyarrhythmia is remarkable.It can significantly control the heart rate and improve dyspnea.

关 键 词：比索洛尔 慢性阻塞性肺疾病支气管哮喘重叠综合症 快速性心律失常 

分 类 号：R563.9[医药卫生—呼吸系统] R562.25[医药卫生—内科学]